SCHEMBL4925909

SCHEMBL4925909

Cc1cccc(NC(=O)c2ccccc2C(=O)NO)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.58
LMNA P02545 4/20 0.58
KDM4E B2RXH2 4/20 0.58
HPGD P15428 4/20 0.58
HTT P42858 3/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPK1 P28482 1/20 0.58
NPC1 O15118 2/20 0.57
TP53 P04637 2/20 0.57
TSHR P16473 2/20 0.57
RAB9A P51151 2/20 0.57
KDR P35968 1/20 0.52
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
POLB P06746 2/20 0.50
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923931 0.93 HSD17B10 (0.54) HSD17B10LMNAKDM4EHPGDHTT
SCHEMBL4923911 0.88 KDR (0.54) HSD17B10LMNAKDM4EHPGDHTT
SCHEMBL10057829 0.83 LMNA (0.64) HSD17B10LMNAKDM4EHPGDHTT
SCHEMBL9493594 0.81 ALDH1A1 (0.62) HSD17B10KDM4EHPGDHTTALDH1A1
SCHEMBL4930820 0.78 NPC1 (0.76) HSD17B10LMNAKDM4EHPGDHTT
SCHEMBL2700502 0.77 HTT (0.60) HSD17B10LMNAKDM4EHPGDHTT
SCHEMBL2702701 0.77 HPGD (0.66) HSD17B10LMNAKDM4EHPGDHTT
SCHEMBL7666549 0.76 MAPT (0.49) HSD17B10LMNAKDM4EHPGDHTT
SCHEMBL4815209 0.75 HPGD (0.62) LMNAKDM4EHPGDALDH1A1MAPK1
SCHEMBL8773443 0.75 HPGD (0.62) LMNAKDM4EHPGDALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HSD17B10 2205/4885LMNA 4560/4885KDM4E 1359/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HSD17B10 2336/4885LMNA 4579/4885KDM4E 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.